Search company, investor...
Caption Health company logo

Caption Health

Founded Year



Grant | Alive

Total Raised


Last Raised

$4.95M | 2 yrs ago

About Caption Health

Caption Health uses deep learning to help medical professionals in developing countries interpret ultrasounds so they can better treat heart disease. The company was founded in 2013 and is based in Brisbane, California.

Headquarters Location

2000 Sierra Point Pkwy Suite 800

Brisbane, California, 94005,

United States


Caption Health's Product Videos

ESPs containing Caption Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

Healthcare / Healthcare Providers Tech

Solutions that leverage machine learning and computer vision for image acquisition, disease detection, triaging, and diagnosis from ultrasounds, MRIs, CT scans, and more.

Caption Health named as Challenger among 8 other companies, including Zebra Medical Vision,, and Shukun Technology.

Compete with Caption Health?

Ensure that your company and products are accurately represented on our platform.

Caption Health's Products & Differentiators

    Preferred In-Network Ultrasound Provider

    Low-cost and convenient ultrasounds wherever a patient is located

Research containing Caption Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Caption Health in 2 CB Insights research briefs, most recently on Feb 16, 2022.

Expert Collections containing Caption Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Caption Health is included in 8 Expert Collections, including Digital Health.


Digital Health

22,454 items

Startups recreating how healthcare is delivered


Artificial Intelligence

9,442 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

12,725 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Digital Health 150

300 items

The winners of the second annual CB Insights Digital Health 150.


Health IT

10,541 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.


AI 100

100 items

Winners of CB Insights' 5th annual AI 100, a list of the 100 most promising private AI companies in the world.

Caption Health Patents

Caption Health has filed 1 patent.

The 3 most popular patent topics include:

  • Medical imaging
  • Medical ultrasonography
  • Medical equipment
patents chart

Application Date

Grant Date


Related Topics




Medical ultrasonography, Medical imaging, Acoustics, Sound, Medical physics


Application Date


Grant Date



Related Topics

Medical ultrasonography, Medical imaging, Acoustics, Sound, Medical physics



Latest Caption Health News

08:30 ET Caption Health Receives Regulatory Approvals for Caption AI™ Technology Platform in Canada and Australia

Nov 10, 2022

News provided by Share this article Share this article Latest approvals position Caption to broadly impact global health by improving access to innovative heart health technology BRISBANE, Calif., Nov. 10, 2022 /PRNewswire/ --  Caption Health , the leader in using AI and services to improve access to heart ultrasound diagnostics, announced new regulatory approvals to market its Caption AI™ technology platform from Health Canada's Medical Devices Directorate and Australia's Therapeutic Goods Administration. Echocardiography is the preferred initial imaging modality for evaluation of patients with suspected heart failure, and Caption Health expects its global growth will enable widespread access to earlier and more accurate cardiac care, especially within underserved populations and regions, as it has begun to do in the U.S. These are the second and third international regulatory approvals this year for Caption AI, following this summer's European CE Mark announcement. The platform, which received its first regulatory clearance through the U.S. Food and Drug Administration in 2020, empowers any health professional to perform a heart ultrasound without prior sonography experience. Over the past year, the company has launched its Caption Care service – bringing innovative diagnostic imaging into clinics and homes at scale for the first time – and partnered with a range of companies to expand the impact of early disease detection and optimize heart failure management. "Our strategic global expansion is about more than market access, it's about patient access," said Steve Cashman, CEO of Caption Health. "For the first time, we have the opportunity to improve and even save millions of lives using cutting-edge technology to identify heart health issues before they become intractable. We're thrilled to be taking these next strides." Broader access to heart ultrasound is critical for global health, as experts estimate 64 million people worldwide – and rising – have heart failure. Because symptoms typically don't arise until late-stage disease, heart failure is commonly diagnosed in a hospital after advanced disease leads to an emergency. Despite the benefits of early detection, in some Canadian provinces, patients can lose more than a year waiting for an echocardiogram. And although early intervention can stop or slow progression and save lives, geography often dictates outcomes: for example, heart failure is endemic and resulting mortality is high among Indigenous Australians living in rural areas. "These new approvals are further confirmation of our strong clinical and regulatory record and a leading indicator of our potential for growth as we work to reduce the global burden of heart disease," said Tahir Rizvi, Head of Regulatory Affairs and Quality Assurance at Caption Health. "We will continue to execute this strategy and expect to make an impact immediately in new markets like Canada next year." Caption Health is a sponsor of HLTH 2022. Learn more and book a live demo at Booth 541: About Caption Health Caption Health has developed the AI platform that enables heart ultrasound access for early disease detection – when there is the highest potential for impact. The company's Caption Care services offer health providers, payers, and value-based care organizations convenient and cost-effective echos for their members, leveraging its Caption AI technology platform. In 2021, Caption Health was recognized as one of TIME's 100 Best Inventions and a winner of Fast Company's Next Big Things in Tech for health. Caption Health's platform is used at leading hospitals, clinics, and physician organizations, and is cited in several peer-reviewed journals including JAMA Cardiology and Journal of the American Society of Echocardiography. For more information, visit . Media Contacts:

Caption Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Caption Health Rank

Caption Health Frequently Asked Questions (FAQ)

  • When was Caption Health founded?

    Caption Health was founded in 2013.

  • Where is Caption Health's headquarters?

    Caption Health's headquarters is located at 2000 Sierra Point Pkwy, Brisbane.

  • What is Caption Health's latest funding round?

    Caption Health's latest funding round is Grant.

  • How much did Caption Health raise?

    Caption Health raised a total of $75.33M.

  • Who are the investors of Caption Health?

    Investors of Caption Health include Bill & Melinda Gates Foundation, Khosla Ventures, DCVC, Atlantic Bridge Capital, Edwards Lifesciences and 15 more.

  • Who are Caption Health's competitors?

    Competitors of Caption Health include Ibex Medical Analytics, EchoNous, Butterfly Network,, Koios Medical, Cleerly, Lunit, Sonio, Aidoc Medical, Pons and 30 more.

  • What products does Caption Health offer?

    Caption Health's products include Preferred In-Network Ultrasound Provider and 3 more.

  • Who are Caption Health's customers?

    Customers of Caption Health include Northwestern Medicine.

Compare Caption Health to Competitors

Ultromics Logo

Ultromics provides autonomous echocardiography analysis through AI solutions, empowering physicians to make decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing reports for clinicians without any need for physical software on-site. The company was founded in 2017 and is based in Oxford, U.K.

Koios Medical Logo
Koios Medical

Koios Medical is a provider of software solutions for radiologists diagnosing cancer. Using AI algorithms trained on thousands of images combined with data from pathology results, Koios DS™ is decision support for healthcare diagnostics. Koios Medical was formerly known as Clearview Diagnostics. The company was founded in 2012 and is based in Chicago, Illinois.

Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.


RadNet is a national provider of diagnostic imaging services in the United States. It offers a range of imaging services including digital and 3D mammography, X-ray, nuclear medicine, dual-energy X-ray absorptiometry (DEXA) for bone density measurement, and more. The company was founded in 1984 and is based in Los Angeles, California.

ScreenPoint Medical Logo
ScreenPoint Medical

ScreenPoint Medical, based in Nijmegen, has developed smart software for improving results of breast cancer screening. This software reads mammograms like a human reader and supports radiologists by identifying and interpreting potential problem areas on x-ray images. This reduces the chance of missing tumors and may be used to organize screening more efficiently.

Infervision Logo

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.